2021
DOI: 10.21886/2712-8156-2021-2-2-104-110
|View full text |Cite
|
Sign up to set email alerts
|

Findings from the EMPEROR-Reduced study are a tool to improve care for patients with chronic heart failure with reduced ejection fraction.Resolution of the Regional Scientific Meeting of Experts of the Southern Federal District

Abstract: At online scientific expert meeting of the South region held on October 3, 2020, the results of the international multicenter study EMPEROR-Reduced were discussed. Number of proposals and recommendations were adopted for the further study of the cardiovascular and renal effects of empagliflozin, its use in clinical practice in patients with chronic heart failure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 10 publications
0
0
0
Order By: Relevance